Survey of Breast Cancer Cell Function Identifies New Drug Uses, Combinations

GRAIL presses on with Galleri test despite missed primary endpoint in pivotal study
Where GRAIL sees signals of benefit in the subgroups, screening experts see signs of overdiagnosis

If you listen to GRAIL executives discuss the results of the long-awaited trial of the company’s multicancer detection test, you might be led to conclude that the company’s pivotal NHS-Galleri study had an overwhelmingly positive result.

March 06, 2026

By Jacquelyn Cobb and Sara Willa Ernst

Conversation with The Cancer Letter

GRAIL’s Megan Hall: “I think we can be confident that there is clinical benefit to implementing this technology. And I think that’s really hard to argue with.”
Mainstream epidemiologists beg to differ

Undeterred by the negative topline result of its pivotal trial of Galleri, a multicancer detection test, the test’s sponsor, GRAIL, said it’s forging ahead with its plan to get FDA approval and reimbursement from CMS and private insurers.

March 06, 2026

By Jacquelyn Cobb and Sara Willa Ernst

Cancer Policy

Mt. Sinai forms committee to probe Epstein links to breast center founder Eva Dubin, other faculty members

Mount Sinai hospital has formed a committee to investigate the ties between Jeffrey Epstein and Eva Dubin a leading doctor at the hospital and founder of the Dubin Breast Center at the Tisch Cancer Institute whose name is featured prominently in the Epstein files.

March 06, 2026

By Claire Marie Porter and Sara Willa Ernst

Cancer Policy

House member introduces bill to increase funding for MCD testing of firefighters

Rep. Josh Gottheimer (D-NJ) introduced the FIRE Cancer Act on Feb. 27. The piece of legislation seeks to increase grant dollars available to local fire departments, specifically earmarked for cancer prevention, “including providing multi-cancer early detection testing or other forms of preventative tests.”

March 06, 2026

By Sara Willa Ernst

In Brief

Kim Rathmell named OSUCCC director, Pollock becomes director emeritus in planned leadership transition

W. Kimryn Rathmell, CEO of the James Cancer Hospital and Solove Research Institute, has also been named director of The Ohio State University Comprehensive Cancer Center in place of former Director Raphael E. Pollock, who has stepped down from the position he had held since November 2017 to become OSUCCC director emeritus.

March 06, 2026

In Brief

Bob Gray steps down as ECOG-ACRIN group statistician

Bob Gray has retired from his role as Group Statistician, Therapeutics, for the ECOG-ACRIN Cancer Research Group, as of Feb. 28.

March 06, 2026

Survey of Breast Cancer Cell Function Identifies New Drug Uses, Combinations

YOU MAY BE INTERESTED IN

GRAIL presses on with Galleri test despite missed primary endpoint in pivotal study
Where GRAIL sees signals of benefit in the subgroups, screening experts see signs of overdiagnosis

GRAIL’s Megan Hall: “I think we can be confident that there is clinical benefit to implementing this technology. And I think that’s really hard to argue with.”
Mainstream epidemiologists beg to differ

Mt. Sinai forms committee to probe Epstein links to breast center founder Eva Dubin, other faculty members

House member introduces bill to increase funding for MCD testing of firefighters

Kim Rathmell named OSUCCC director, Pollock becomes director emeritus in planned leadership transition

Bob Gray steps down as ECOG-ACRIN group statistician

Renew today!

Subscriber content

Never miss an issue!

Login

Survey of Breast Cancer Cell Function Identifies New Drug Uses, Combinations

YOU MAY BE INTERESTED IN

GRAIL presses on with Galleri test despite missed primary endpoint in pivotal studyWhere GRAIL sees signals of benefit in the subgroups, screening experts see signs of overdiagnosis

GRAIL’s Megan Hall: “I think we can be confident that there is clinical benefit to implementing this technology. And I think that’s really hard to argue with.”Mainstream epidemiologists beg to differ

Mt. Sinai forms committee to probe Epstein links to breast center founder Eva Dubin, other faculty members

House member introduces bill to increase funding for MCD testing of firefighters

Kim Rathmell named OSUCCC director, Pollock becomes director emeritus in planned leadership transition

Bob Gray steps down as ECOG-ACRIN group statistician

Never miss an issue!

Login

GRAIL presses on with Galleri test despite missed primary endpoint in pivotal study
Where GRAIL sees signals of benefit in the subgroups, screening experts see signs of overdiagnosis

GRAIL’s Megan Hall: “I think we can be confident that there is clinical benefit to implementing this technology. And I think that’s really hard to argue with.”
Mainstream epidemiologists beg to differ